ヨーロッパ眼科市場
Market Size in USD Billion
CAGR :
% 
USD
22.23 Billion
USD
38.00 Billion
2024
2032
 予測期間 |
2025 –2032 |
 市場規模（基準年） |
USD 22.23 Billion |
 Market Size (Forecast Year) |
USD 38.00 Billion |
 CAGR |
% |
| 主要市場プレーヤー |
ヨーロッパ眼科市場のセグメンテーション、製品別（デバイス、医薬品、その他）、疾患別（白内障、屈折異常、緑内障、加齢黄斑変性、炎症性疾患、その他）、総合眼科検査（屈折検査、視力検査、眼圧検査、前眼部および瞳孔検査、視野検査、色覚検査、その他）、エンドユーザー別（クリニック、病院、在宅医療、その他）、流通チャネル別（小売販売、直接入札、その他） - 2032年までの業界動向と予測
ヨーロッパ眼科市場分析
ヨーロッパの眼科市場は、エジプトやギリシャにおける古代の眼疾患治療法に始まり、数世紀にわたり大きく発展してきました。この分野は、より高度な外科手術技術と器具の開発に伴い、17世紀と18世紀に形成され始めました。19世紀には、検眼鏡などの革新が診断能力を変革しました。20世紀には、白内障手術や眼内レンズの発明といった画期的な進歩があり、1990年代にはレーシック手術が導入されました。21世紀は、人口の高齢化、技術の進歩、そして光干渉断層撮影（OCT）や網膜画像システムといった特殊な診断・手術機器の開発に牽引され、継続的な成長を遂げました。近年のトレンドは、人工知能、遠隔医療、そして遺伝子治療や幹細胞治療といった生物学的療法の利用拡大に重点が置かれており、市場の成長をさらに促進しています。今日、眼科市場は、眼疾患の罹患率の上昇、新しい技術、治療オプションの進化により拡大し続けています。
ヨーロッパの眼科市場規模
欧州の眼科市場は、2025年から2032年の予測期間に年平均成長率7.0%で成長し、2024年の222.3億米ドルから2032年には380億米ドルに達すると予想されています。
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。
欧州眼科市場動向
「遠隔医療とAIを活用した診断ツールの導入拡大」
欧州の眼科市場では、遠隔医療やAIを活用した診断ツールの導入が進んでいます。これらの技術革新により、遠隔地での診察やスクリーニングが可能になり、特に医療サービスが行き届いていない地域や農村部でのアクセス性が向上し、眼科医療の提供方法が変革しています。機械学習アルゴリズムを含むAI技術は、網膜画像の分析、糖尿病網膜症、緑内障、黄斑変性症などの早期兆候の検出、より迅速で正確な診断の提供に利用されています。遠隔医療プラットフォームを利用することで、患者は眼科医と連絡を取り、フォローアップの診察を受けることができ、対面診療の必要性が減り、眼科医療の利便性と効率が向上します。この傾向は、患者がタイムリーな治療を受けられるようになるだけでなく、医療システム全体の効率性も向上させ、眼科分野の市場成長を促進する重要な要因となっています。その結果、これらの技術の統合は、特に医療インフラがまだ発展途上にある新興市場において、拡大し続けると予想されます。
レポートの範囲とヨーロッパ眼科市場のセグメンテーション
|
属性 |
ヨーロッパ眼科市場の洞察 |
|
対象セグメント |
製品別：デバイス、医薬品、その他 疾患別：白内障、屈折異常、緑内障、加齢黄斑変性、炎症性疾患など 総合的な 眼科 検査：屈折検査、視力検査、眼圧検査、前眼部・瞳孔検査、視野検査、色覚検査など エンドユーザー別：診療所、病院、在宅医療、その他 流通 チャネル別：小売販売、直接入札、その他 |
|
対象地域 |
ドイツ、フランス、イギリス、イタリア、スペイン、スイス、ロシア、ベルギー、オランダ、トルコ、その他のヨーロッパ諸国 |
|
主要な市場プレーヤー |
アルコン（スイス）、ボシュロム（カナダ）、カールツァイスメディテック（ドイツ）、HOYA株式会社（日本）、ジョンソン・エンド・ジョンソン・サービス株式会社（米国）、エシロールインターナショナル（フランス）、株式会社トプコン（日本）、グラウコス株式会社（米国）、ハーグ・シュトライトグループ（スイス）、ニデック株式会社（米国）、スタールサージカル（カリフォルニア州）、ジーマー・オフタルミック・システムズ株式会社（スイス）、クーパー・カンパニーズ株式会社（米国）、ルミナス・ビー株式会社（イスラエル）、ライヒェルト株式会社（ニューヨーク）、バイエル株式会社（ドイツ）、ノバルティス株式会社（スイス）、アッヴィ株式会社（米国）、F.ホフマン・ラ・ロシュ株式会社（スイス）、ドンペ株式会社（イタリア）、参天製薬株式会社（日本）他 |
|
市場機会 |
|
|
付加価値データ情報セット |
データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。 |
欧州眼科市場の定義
眼科は、眼の疾患や障害の診断、治療、予防に重点を置いた医学および外科の一分野です。白内障、緑内障、黄斑変性、糖尿病網膜症など、眼や視覚系に影響を与える疾患に対する医学的および外科的治療が含まれます。
欧州眼科市場の定義と動向
ドライバー
ドライバー
- 眼疾患の罹患率の増加
白内障、黄斑変性、糖尿病網膜症といった眼疾患の増加は、欧州眼科市場の大きな牽引力となっています。欧州では人口の高齢化に伴い、これらの疾患の発症率も上昇しています。白内障は視力低下や失明につながるため、手術や矯正治療の市場拡大が求められています。同様に、黄斑変性と糖尿病網膜症は、高度な診断ツールと専門的な治療法の必要性を高めています。患者数の増加は、手術、投薬、革新的な診断技術を含む眼科サービスへの継続的な需要を確実なものにしています。こうした眼疾患の急増は市場拡大の直接的な原動力となっており、医療提供者とメーカーは効果的な治療法とソリューションへの高まる需要に応えようと努力しています。
例えば、
- 2022年7月、NCBIが発表した論文によると、失明率は加齢とともに上昇し、50～59歳では0.45%であるのに対し、80歳以上では11.62%に増加しています。女性（2.31%）と地方居住者（2.14%）では失明率がさらに高くなっています。視覚障害も26.68%に見られ、同様の傾向を示しています。特に高齢者における眼疾患の増加は、眼科治療と技術の需要を押し上げ、眼科市場を押し上げています。
- 2023年8月、WHO欧州委員会が発表した記事によると、22億人以上が視力障害に苦しんでおり、そのうち約10億件は予防可能または未治療です。視力障害の罹患率の増加は、眼科サービス、治療、そして矯正ソリューションに対する需要の高まりを浮き彫りにしています。予防可能または未治療の症状で医療機関を受診する人が増えるにつれ、眼疾患の負担増加は眼科市場の大きな牽引力となっています。
白内障、黄斑変性、糖尿病網膜症といった加齢に伴う眼疾患の増加は、ヨーロッパの眼科市場を牽引しています。人口の高齢化に伴い、これらの疾患はより一般的になり、治療、手術、そして診断ツールへの需要が高まっています。ケアを必要とする人が増えるにつれて、高度な技術と治療法へのニーズも高まります。こうした眼疾患の急増は市場の成長を牽引し、医療提供者とメーカーは効果的なソリューションへの需要の高まりに対応しようとしています。
- 予防的な目のケアに焦点を当てる
予防的な眼科ケアと視力関連の問題の早期発見の重要性が高まっており、これが欧州の眼科市場を牽引する上で重要な役割を果たしています。目の健康の重要性に対する認識が高まるにつれ、緑内障、糖尿病網膜症、白内障などの疾患を早期に発見するために、定期的な眼科検診を受ける人が増えています。早期診断はタイムリーな介入を可能にし、視力低下のリスクを軽減し、眼の健康全般を改善します。この積極的なアプローチは、患者の転帰を改善するだけでなく、眼科サービス、診断ツール、矯正治療への需要を高めています。予防ケアへの関心の高まりは、眼科ケア技術、眼科機器、サービスへの投資の急増につながり、市場の拡大に貢献しています。この傾向は、眼科分野の成長を強く牽引しています。
例えば、
- 2022年10月、国立眼科研究所が発表した記事によると、国立眼科健康教育プログラム（NEHEP）は医療専門家と協力し、眼疾患の早期発見、治療、そして視力リハビリテーションのメリットに関する意識向上に取り組んでいます。また、眼疾患や視力低下のリスクが高い人々も対象としています。予防ケアに重点を置くことで、人々は適切な時期に眼科検診や治療を受けるようになり、眼科サービス、診断ツール、製品への需要が高まり、眼科市場の成長を促しています。
- 保健サービス総局が2024年10月に発表した記事によると、国家失明・視覚障害管理プログラム（NPCB&VI）は、あらゆる医療レベルで治癒可能な失明を特定し治療することで、失明率の低減を目指しています。早期発見と回避可能な失明への対応に重点を置くことで、このプログラムは予防ケアの重要性を強調しています。この取り組みは、眼科サービス、診断ツール、治療に対する需要を促進し、欧州眼科市場の成長に大きく貢献するでしょう。
The increasing focus on preventative eye care and early detection is significantly driving the Europe ophthalmology market. As awareness of eye health rises, more individuals are opting for routine eye exams to identify conditions like glaucoma and cataracts early. Early detection allows for effective treatments that prevent further vision loss. This proactive approach is driving demand for diagnostic tools, ophthalmic services, and corrective treatments. The growing importance of preventative care is prompting investment in advanced eye care technologies, thus contributing to the overall growth of the ophthalmology market and ensuring its continued expansion.
Opportunities
- Rise in the Aging Population
The rise in the aging population presents a significant opportunity for the Europe ophthalmology market, as older individuals are more susceptible to various eye disorders and diseases. Conditions such as cataracts, age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma are prevalent among the elderly, creating a substantial demand for ophthalmic care and treatments. As a result, healthcare systems and ophthalmic providers are poised to expand their services, enhance diagnostic and therapeutic options, and cater to the unique needs of this demographic. This growing patient base necessitates an array of solutions, from surgical interventions and advanced drug therapies to vision correction products, ensuring a steady and increasing demand for ophthalmic procedures and products.
For instance,
- In March 2023, according to an article published in the National Library of Medicine, Cataract is a leading cause of visual impairment in old age. Lens opacification is notoriously associated with several geriatric conditions, including frailty, fall risk, depression and cognitive impairment. Moreover, according to the same source, in 2020, the leading worldwide causes of blindness in patients aged 50 years and older were cataract, followed by glaucoma, under-corrected refractive error, age-related macular degeneration, and diabetic retinopathy
- In August 2022, according to an article published in the American Academy of Ophthalmology, AMD is a common eye disease, usually found in adults over the age of 50. Moreover, it is stated that Half of Americans over the age of 75 develop cataracts
Moreover, addressing the eye health needs of the aging population can stimulate further investments in research and development within the ophthalmology sector. Pharmaceutical companies and medical device manufacturers are focus on creating innovative solutions tailored specifically for age-related conditions, potentially leading to breakthroughs in treatment protocols and patient care. The integration of new technologies, such as tele ophthalmology and advanced imaging techniques, facilitate better management of eye health in older adults, making it easier to monitor and treat conditions remotely. Overall, the aging population amplifies the need for existing ophthalmic services and presents a fertile ground for innovation and growth within the Europe ophthalmology market.
- Rise in Online Retail and E-Health Platforms
The rise of online retail and e-health platforms offers a significant opportunity for the Europe ophthalmology market by providing consumers with easier access to a wide array of eye care products and services. With the increasing adoption of e-commerce, patients can conveniently purchase items such as prescription glasses, contact lenses, and over-the-counter eye care products from the comfort of their homes. This trend is especially appealing to younger, tech-savvy consumers and those in remote areas with limited access to traditional optical stores. The ability to compare prices, read reviews, and access a wider range of products online enhances customer satisfaction and encourages usage, thereby driving growth in the ophthalmic product segment.
For instance,
- In September 2023, according to a news article from The Times of India, the 'pink eye' outbreak led to a surge in sales of ophthalmology medicine. Sales jumped nearly 30% year-on-year for the second month in a row in August - outgrowing the overall market by almost five times. The rise reflects the massive incidence of conjunctivitis and eye-complications in the last few months across the country
- In April 2020, according to an article, ‘Patient views about online purchasing of eyewear’, online purchasing of contact lenses is on the rise: 10%–20% of contact lens wearers in Australia, U.S. and the UK have considered or researched the possibility of Internet purchasing
In addition to retail opportunities, e-health platforms facilitate telehealth services that allow patients to consult with eye care professionals remotely. Virtual consultations for routine eye examinations, follow-ups, and triaging for more serious conditions can significantly improve access to care, particularly for older adults or individuals with mobility challenges. These platforms enhance patient engagement and adherence to eye health recommendations and allow ophthalmologists to reach a broader patient base without the constraints of geographic boundaries. Furthermore, the integration of digital health tools, such as mobile apps for monitoring eye health or managing chronic conditions, can create a seamless patient experience and foster proactive eye care, further propelling growth in the ophthalmology market.
Restraints/Challenges
- Side Effects and Complications Related to Eye Surgeries
Despite the significant advancements in ophthalmology treatments, certain ophthalmic procedures, particularly surgical interventions, carry risks of side effects and complications such as infection, scarring, or vision impairment. These potential risks can deter patients from undergoing specific therapies, especially those that involve invasive procedures. The fear of adverse outcomes, such as reduced vision or prolonged recovery times, can lead to hesitancy in seeking treatment, limiting the overall adoption of certain therapies. Additionally, complications arising from surgeries might require additional treatments, further raising healthcare costs and impacting patient trust in advanced treatments. This reluctance to undergo treatments due to the potential for negative side effects restricts the overall growth of the ophthalmology market by slowing down the adoption of new technologies and therapies.
For instance,
- In October 2024, according to the article published by Harvard Health, Modern eye surgeries, while effective in treating conditions like cataracts and glaucoma, often lead to complications such as dry eye disease, characterized by a burning, gritty, or itchy sensation. This side effect can be uncomfortable and discouraging for patients, leading some to hesitate or avoid eye surgeries. As a result, complications from treatments act as a restraint on the growth of the ophthalmology market
- In July 2021, according to the article published by Medical News Today, Up to 95% of individuals who undergo laser eye surgery may experience dry eyes, while 20% report visual disturbances like glare or halos. Additionally, 1 in 50 people may suffer from blurry vision or “sands of Sahara” syndrome. These side effects can discourage patients from opting for surgery, limiting the adoption of laser procedures and acting as a restraint on the ophthalmology market’s growth
眼科医療は進歩を遂げていますが、一部の外科治療には感染症、瘢痕、視力障害などのリスクが伴います。これらの合併症は、患者が特定の治療法、特に侵襲的な治療法を選択することを躊躇させる要因となっています。副作用や追加治療費への不安は、患者の治療意欲を低下させ、新しい治療法の導入を遅らせる可能性があります。こうした消極的な姿勢が、欧州の眼科市場の成長を阻害しています。
- 地方における専門的な眼科医療へのアクセスの制限
医療インフラの進歩にもかかわらず、農村部や遠隔地では専門的な眼科医療へのアクセスが依然として限られており、これらの地域における眼科市場の成長ポテンシャルを大きく阻害しています。多くの農村部では、訓練を受けた眼科専門家の不足、設備の不足、高度な診断・治療技術へのアクセスの制限といった課題が依然として存在しています。その結果、これらの地域の人々は、眼疾患の適切な診断と治療を受けるのに苦労することが多く、予防可能な失明や視力障害の発生率が高まっています。専門的なケアへのアクセスが限られているため、高度な眼科サービスや製品の導入が抑制され、市場拡大が阻害されています。こうしたアクセス障壁は、ヨーロッパの眼科市場全体の成長を阻害する大きな要因となっています。
例えば、
- 2023年2月、NCBIが発表した論文によると、インドの農村人口は膨大で、満たされていない眼科医療ニーズが深刻であり、医療施設や専門家の大半は都市部および準都市部に集中しています。農村部と都市部における眼科医療へのアクセス格差は依然として課題であり、治療へのアクセスを制限しています。この医療資源の不平等な配分は、農村部における必須サービスへの広範なアクセスを阻害し、欧州の眼科市場の成長を阻害しています。
- 2024年3月、リサーチゲートが発表した記事によると、「遠隔地では、インターネット接続や訓練を受けたスタッフが不足しているため、眼科キャンプが成功した後でも、継続的な眼科ケアへのアクセスが妨げられています。これらの地域の患者は、適切なインフラが整備されていないため、フォローアップケアや高度な治療を受けるのに苦労しています。この医療提供のギャップは、眼科ケアプログラムの範囲と効果を制限し、ヨーロッパの眼科市場の成長を阻害しています。」
医療体制の改善にもかかわらず、地方では専門的な眼科医療へのアクセスが依然として限られています。眼科医療従事者、高度な技術、そして設備の不足により、適切な治療と診断が受けられず、回避可能な失明率の上昇につながっています。こうしたアクセスの制限は、これらの地域における高度な治療やサービスの導入を制限し、欧州眼科市場の成長を阻害しています。
欧州眼科市場の範囲
市場は、製品、疾患、総合眼科検査、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメント間の成長は、業界における成長の少ないセグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供し、コア市場アプリケーションを特定するための戦略的意思決定を支援します。
製品別
- デバイス
- 外科用デバイス
- 白内障手術器具
- 眼科用粘弾性デバイス
- 超音波乳化吸引装置
- 白内障手術用レーザー
- IOLインジェクター
- 硝子体網膜手術デバイス
- 硝子体切除術装置
- 硝子体網膜パック
- 光凝固レーザー
- 硝子体切除プローブ
- 照明装置
- 屈折矯正手術機器
- フェムト秒レーザー
- エキシマレーザー
- その他の屈折手術用レーザー
- 緑内障手術機器
- 緑内障ドレナージ装置
- 微小侵襲緑内障手術デバイス
- 緑内障レーザーシステム
- 診断装置
- 光干渉断層撮影（OCT）スキャナ
- オートレフラクトメーターと角膜計
- 眼圧計
- フォロプター
- 網膜鏡
- 検眼鏡
- スリットランプ
- 視野計/視野分析装置
- 角膜トポグラフィーシステム
- 眼底カメラ
- 眼科用超音波画像システム
- Aスキャンイメージングシステム
- Bスキャンイメージングシステム
- パキメーター
- 超音波生体顕微鏡
- レンズメーター
- 波面収差計
- 光学生体測定システム
- スペキュラー顕微鏡
- チャートプロジェクター
- 眼科手術用アクセサリー
- 手術器具とキット
- 眼科用鉗子
- 眼科用スパチュラ
- 眼科用チップとハンドル
- 眼科用カニューラ
- 眼科用はさみ
- その他外科用アクセサリー
- 眼科用顕微鏡
- 外科用デバイス
- 医薬品、副産物
- 抗VEGF薬
- ラニビズマブ
- ベバシズマブ
- 網膜疾患治療薬
- 緑内障治療薬
- プロスタグランジン類似体
- ラタノプロスト
- ビマトプロスト
- トラボプロスト
- タフルプロスト
- ラタノプロステン
- βアドレナリン拮抗薬
- チモラールマレイン酸塩
- ベタキソロール
- アルファアドレナリン作動薬
- エピネフリン
- デピベプリン
- 縮瞳薬
- ピロカルピン
- 彼の作品に
- プロスタグランジン類似体
- ドライアイ薬
- 抗炎症薬
- ステロイド系抗炎症薬
- 非ステロイド性抗炎症薬
- アレルギー性結膜炎の薬
- その他
- 抗VEGF薬
- 薬物、薬物の種類別
- ブランド
- ジェネリック
- 処方モード別医薬品
- 処方箋
- 店頭
- 投与経路別薬剤
- トピック
- 目薬
- アイソリューション
- クリームと軟膏
- ゲル
- その他
- 地元の眼科
- 硝子体内
- 結膜下
- 球後部
- 前房内
- 注射剤
- 筋肉内
- 静脈内
- その他
- オーラル
- 錠剤
- カプセル
- その他
- その他
- トピック
- その他
- 視力ケア製品
- 眼鏡
- コンタクトレンズ
- ソフトコンタクトレンズ
- ハイブリッドコンタクトレンズ
- 硬質ガス透過性レンズ
- その他
- 視力ケア製品
病気別
- 白内障
- 屈折異常
- 緑内障
- 加齢黄斑変性症
- 炎症性疾患
- その他
総合的な眼科検査によって
- 屈折
- 自動屈折計
- トライアルレンズセット
- 毛様体麻痺薬
- トライアルフレーム
- 自己照明型/ミラーレチノスコープ
- ジャクソンクロスシリンダー
- 視力検査
- スネレンチャート
- 近視力表
- 眼圧
- 眼圧計（ゴールドマン、トノペン、パーキンス、シオッツ）
- その他
- 前眼部および瞳孔検査
- スリットランプ生体顕微鏡
- トーチライト
- 視野検査
- セントラル30-2全閾値ハンフリー視野分析装置
- Frequency Doubling Perimeter
- Goldmann Kinetic Perimeter
- Color Vision Test
- Others
By End User
- Clinics
- Hospitals
- Home Healthcare
- Others
By Distribution Channel
- Retail sales
- Retail Shops
- Hospital Pharmacy
- Online Pharmacy
- Direct Tender
- Others
Europe Ophthalmology Market Regional Analysis
The market is segmented on the basis of products, diseases, comprehensive eye examination, end user, and distribution channel.
The countries covered in this market are Germany, France, U.K., Italy, Spain, Switzerland, Russia, Belgium, Netherlands, Turkey, and rest of Europe.
Germany is expected to dominate the market due to advanced healthcare infrastructure, high healthcare spending, and a large aging population with a growing prevalence of eye diseases. Additionally, significant investments in research, development, and the adoption of cutting-edge technologies drive market leadership in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Europe Ophthalmology Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Europe Ophthalmology Market Leaders Operating in the Market Are:
- Alcon (Switzerland)
- Bausch + Lomb (Canada)
- Carl Zeiss Meditec( Germany)
- Hoya Corporation (Japan)
- Johnson & Johnson Services, Inc. (U.S.)
- Essilor International (France)
- Topcon Corporation(Japan)
- Glaukos Corporation (U.S.)
- Haag-Streit Group (Switzerland)
- Nidek Co., Ltd (U.S.)
- Staar Surgical (California)
- Ziemer Ophthalmic Systems Ag (Switzerland)
- Cooper Companies (U.S.)
- Lumenis Be Ltd. (Israel)
- Reichert Inc. (New York)
- Bayer Ag (Germany)
- Novartis Ag (Switzerland)
- Abbvie Inc. (U.S.)
- F. Hoffmann-La Roche Ltd.(Switzerland)
- Dompé (Italy)
- Santen Pharmaceutical Co.(Japan)
Latest Developments in Europe Ophthalmology Market
- In October 2024, At the AAO 2024 meeting, Alcon showcased its innovations, including the Voyager DSLT for glaucoma treatment, UNIFEYE and UNIPEXY handheld gas delivery systems, and pivotal data for AR-15512, a dry eye treatment. These advancements aimed to improve outcomes and surgical efficiency
- In September 2024, EssilorLuxottica and Meta have extended their partnership, entering a long-term agreement to develop multi-generational smart eyewear products. Building on the success of Ray-Ban Meta glasses, the companies aim to shape the future of wearable technology together
- In OCTOBER 2024, Bausch + Lomb presented new scientific data and educational events at the 2024 AAO meeting in Chicago. Highlights included studies on the enVista Envy IOL, TENEO Excimer Laser, VYZULTA, and presentations on Blink Nutritears, MIEBO, and Xiidra
- In April 2024, AbbVie has completed its acquisition of Cerevel Therapeutics, enhancing its neuroscience portfolio. The acquisition includes Cerevel’s promising clinical-stage assets like Emraclidine for schizophrenia and Tavapadon for Parkinson's disease, strengthening AbbVie’s position in neurology and psychiatry
- In September, 2023, Novartis completed the divestment of its 'front of eye' ophthalmology assets to Bausch + Lomb for up to USD 2.5 billion, including USD 1.75 billion in upfront cash and potential milestone payments. The deal included Xiidra®, SAF312, AcuStream, and OJL332. Novartis advanced its strategy to focus on prioritized therapeutic areas for future growth
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE OPHTHALMOLOGY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 EUROPE OPHTHALMOLOGY MARKET : REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF EYE DISEASES
6.1.2 FOCUS ON PREVENTATIVE EYE CARE
6.1.3 GOVERNMENT EYECARE INITIATIVES
6.1.4 INNOVATIONS IN OPHTHALMIC SURGICAL TECHNIQUES
6.2 RESTRAINTS
6.2.1 SIDE EFFECTS AND COMPLICATIONS RELATED TO EYE SURGERIES
6.2.2 LIMITED ACCESS TO SPECIALIZED OPHTHALMIC CARE IN RURAL AREAS
6.3 OPPORTUNITIES
6.3.1 RISE IN THE AGING POPULATION
6.3.2 RISE IN ONLINE RETAIL AND E-HEALTH PLATFORMS
6.3.3 ENHANCED PATIENT EDUCATION
6.4 CHALLENGES
6.4.1 RISING COSTS OF OPHTHALMIC TREATMENTS
6.4.2 SHORTAGE OF EYE CARE PROFESSIONALS
7 EUROPE OPHTHALMOLOGY MARKETEUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS
7.1 OVERVIEW
7.2 DEVICE
7.2.1 SURGICAL DEVICE
7.2.1.1 CATARACT SURGICAL DEVICES
7.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES
7.2.1.2.1 PHACOEMULSIFICATION DEVICES
7.2.1.2.2 CATARACT SURGICAL LASERS
7.2.1.2.3 IOL INJECTORS
7.2.1.3 VITREORETINAL SURGICAL DEVICES
7.2.1.3.1 VITREORETINAL PACKS
7.2.1.3.2 VITRECTOMY MACHINES
7.2.1.3.3 VITRECTOMY PROBES
7.2.1.3.4 PHOTOCOAGULATION LASERS
7.2.1.3.5 ILLUMINATION DEVICES
7.2.1.4 REFRACTIVE SURGICAL DEVICES
7.2.1.4.1 FEMTOSECOND LASERS
7.2.1.4.2 EXCIMER LASERS
7.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS
7.2.1.5 GLAUCOMA SURGICAL DEVICES
7.2.1.5.1 GLAUCOMA DRAINAGE DEVICES
7.2.1.5.2 GLAUCOMA LASER SYSTEMS
7.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES
7.2.2 DIAGNOSTIC DEVICE
7.2.2.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS
7.2.2.2 AUTOREFRACTORS & KERATOMETERS
7.2.2.3 TONOMETERS
7.2.2.4 PHOROPTERS
7.2.2.5 RETINOSCOPES
7.2.2.6 OPHTHALMOSCOPES
7.2.2.7 SLIT LAMPS
7.2.2.8 PERIMETERS/VISUAL FIELD ANALYZERS
7.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS
7.2.2.10 FUNDUS CAMERAS
7.2.2.11 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
7.2.2.11.1 A- SCAN IMAGING SYSTEM
7.2.2.11.2 B-SCAN IMAGING SYSTEM
7.2.2.11.3 PACHYMETERS
7.2.2.11.4 ULTRASOUND BIOMICROSCOPES
7.2.2.12 LENSMETERS
7.2.2.13 WAVEFRONT ABERROMETERS
7.2.2.14 OPTICAL BIOMETRY SYSTEMS
7.2.2.15 SPECULAR MICROSCOPES
7.2.2.16 CHART PROJECTORS
7.2.3 OPHTHALMIC SURGICAL ACCESSORIES
7.2.3.1 SURGICAL INSTRUMENTS & KITS
7.2.3.2 OPHTHALMIC FORCEPS
7.2.3.3 OPHTHALMIC SPATULA
7.2.3.4 OPHTHALMIC TIPS AND HANDLES
7.2.3.5 OPHTHALMIC CANNULAS
7.2.3.6 OPHTHALMIC SCISSORS
7.2.3.7 OTHERS SURGICAL ACCESSORIES
7.2.4 OPHTHALMIC MICROSCOPES
7.3 DRUGS
7.3.1 ANTI-VEGF DRUGS
7.3.1.1 RANIBIZUMAB
7.3.1.2 BEVACIZUMAB
7.3.2 ANTI-GLAUCOMA DRUGS
7.3.2.1 PROSTAGLANDIN ANALOGS
7.3.2.1.1 LATANOPROST
7.3.2.1.2 BIMATOPROST
7.3.2.1.3 TRAVOPROST
7.3.2.1.4 TAFLUPROST
7.3.2.1.5 LATANOPROSTENE
7.3.2.2 BETA ADRENERGIC ANTAGONISTS
7.3.2.2.1 TIMOLAL MALEATE
7.3.2.2.2 BETAXOLOL
7.3.2.3 ALPHA ADRENERGIC AGONISTS
7.3.2.3.1 EPINEPHRINE
7.3.2.3.2 DEPIVEPRINE
7.3.2.4 MIOTICS
7.3.2.4.1 PILOCARPINE
7.3.2.4.2 ESERINE
7.3.3 ANTI-INFLAMMATION DRUGS
7.3.3.1 STEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
7.3.4 RETINAL DISORDER DRUGS
7.3.5 DRY EYE DRUGS
7.3.6 ALLERGIC CONJUCTIVITIS DRUGS
7.3.7 OTHERS
7.3.7.1 BRANDED
7.3.7.2 GENERIC
7.3.7.3 PRESCRIPTION
7.3.7.4 OVER THE COUNTER
7.3.7.5 TOPICAL
7.3.7.6 LOCAL OCULAR
7.3.7.7 INJECTABLES
7.3.7.8 ORAL
7.3.7.9 OTHERS
7.3.7.10 EYE DROPS
7.3.7.11 EYE SOLUTION
7.3.7.12 CREAM & OINTMENTS
7.3.7.13 GEL
7.3.7.14 OTHERS
7.3.7.15 INTRAVITREAL
7.3.7.16 SUBCONJUNCTIVAL
7.3.7.17 RETROBULBAR
7.3.7.18 INTRACAMERAL
7.3.7.19 INTRAMUSCULAR
7.3.7.20 INTRAVENOUS
7.3.7.21 OTHERS
7.3.7.22 TABLET
7.3.7.23 CAPSULES
7.3.7.24 OTHERS
7.4 OTHERS
7.4.1 VISION CARE PRODUCTS
7.4.1.1 SPECTACLES
7.4.1.2 CONTACT LENSES
7.4.1.2.1 SOFT CONTACT LENSES
7.4.1.2.2 HYBRID CONTACT LENSES
7.4.1.2.3 RIGID GAS PERMEABLE LENSES
7.4.2 OTHERS
8 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES
8.1 OVERVIEW
8.2 CATARACT
8.3 REFRACTIVE DISORDERS
8.4 GLAUCOMA
8.5 AGE-RELATED MACULAR DEGENERATION
8.6 INFLAMMATORY DISEASES
8.7 OTHERS
9 EUROPE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION
9.1 OVERVIEW
9.2 REFRACTION
9.2.1 AUTOMATED REFRACTOMETERS
9.2.2 SET OF TRIAL LENSES
9.2.3 CYCLOPLEGIC DRUGS
9.2.4 TRIAL FRAME
9.2.5 SELF-ILLUMINATED/ MIRROR RETINOSCOPE
9.2.6 JACKSON CROSS CYLINDER
9.3 VISUAL ACUITY TEST
9.3.1 SNELLEN'S CHART
9.3.2 NEAR VISION CHARTS
9.4 INTRAOCULAR PRESSURE
9.4.1 TONOMETERS (GOLDMANN, TONO-PEN, PERKINS, SHIOTZ)
9.4.2 OTHERS
9.5 ANTERIOR SEGMENT AND PUPILLARY EXAMINATION
9.5.1 SLIT LAMP BIOMICROSCOPE
9.5.2 TORCH LIGHT
9.6 VISUAL FIELDS TEST
9.6.1 CENTRAL 30-2 FULL THRESHOLD HUMPHREY VISUAL FIELD ANALYZER
9.6.2 FREQUENCY DOUBLING PERIMETER
9.6.3 GOLDMANN KINETIC PERIMETER
9.7 COLOR VISION TEST
9.8 OTHERS
10 EUROPE OPHTHALMOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 CLINICS
10.3 HOSPITALS
10.4 HOME HEALTHCARE
10.5 OTHERS
11 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 RETAIL SALES
11.2.1 RETAIL SHOPS
11.2.2 HOSPITAL PHARMACY
11.2.3 ONLINE PHARMACY
11.3 DIRECT TENDER
11.4 OTHERS
12 EUROPE OPHTHALMOLOGY MARKET BY GEOGRAPHY
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 U.K.
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 SWITZERLAND
12.1.7 RUSSIA
12.1.8 BELGIUM
12.1.9 NETHERLANDS
12.1.10 TURKEY
12.1.11 REST OF EUROPE
13 EUROPE OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ALCON
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.2 JOHNSON & JOHNSON SERVICES, INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ESSILOR LUXOTTICA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 NOVARTIS AG
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 BAUSCH + LOMB
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 REVENUE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ABBVIE INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BAYER AG
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 CARL ZEISS MEDITEC AG
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 COOPER COMPANIES
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.1 DOMPÉ
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 F. HOFFMANN-LA ROCHE LTD
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 GLAUKOS CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 HAAG-STREIT
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 HOYA CORPORATION
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 LUMENIS BE LTD.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 NIDEK CO.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 REICHERT, INC
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 SANTEN PHARMACEUTICAL CO.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 STAAR SURGICAL
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
15.2 TOPCON CORPORATION
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENT
15.21 ZIEMER OPHTHALMIC SYSTEMS AG
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表のリスト
TABLE 1 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 2 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 3 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 4 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 5 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 6 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 7 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 8 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 9 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 10 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 11 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 12 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 13 EUROPE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 14 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 15 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 16 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 17 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 18 EUROPE ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)
TABLE 19 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 20 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 21 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 22 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 23 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 24 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 25 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 26 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 27 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 28 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 29 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 30 EUROPE CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 31 EUROPE REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 32 EUROPE GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 33 EUROPE AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 34 EUROPE INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 35 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 36 EUROPE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 37 EUROPE REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 38 EUROPE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 39 EUROPE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 40 EUROPE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 41 EUROPE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 42 EUROPE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 43 EUROPE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 44 EUROPE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 45 EUROPE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 46 EUROPE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 47 EUROPE COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 48 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 49 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 50 EUROPE CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 51 EUROPE HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 52 EUROPE HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 53 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 54 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 55 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 56 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 57 EUROPE DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 58 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)
TABLE 59 EUROPE OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60 EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 61 EUROPE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 62 EUROPE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 63 EUROPE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 64 EUROPE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 65 EUROPE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 66 EUROPE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 67 EUROPE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 68 EUROPE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 69 EUROPE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 70 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 71 EUROPE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 72 EUROPE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 73 EUROPE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 74 EUROPE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 75 EUROPE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 76 EUROPE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 77 EUROPE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 78 EUROPE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 79 EUROPE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 80 EUROPE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 81 EUROPE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 82 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 83 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 84 EUROPE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85 EUROPE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 86 EUROPE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 87 EUROPE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 88 EUROPE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 89 EUROPE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 90 EUROPE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 91 EUROPE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 92 EUROPE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 93 EUROPE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 94 EUROPE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 95 EUROPE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 96 EUROPE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97 EUROPE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98 GERMANY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 99 GERMANY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 100 GERMANY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 101 GERMANY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 102 GERMANY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 103 GERMANY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 104 GERMANY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 105 GERMANY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 106 GERMANY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 107 GERMANY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 108 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 109 GERMANY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 110 GERMANY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 111 GERMANY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 112 GERMANY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 113 GERMANY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 114 GERMANY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 115 GERMANY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 116 GERMANY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 117 GERMANY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 118 GERMANY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 119 GERMANY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 120 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 121 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 122 GERMANY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 123 GERMANY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124 GERMANY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 125 GERMANY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 126 GERMANY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127 GERMANY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 128 GERMANY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 129 GERMANY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 130 GERMANY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 131 GERMANY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 132 GERMANY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 133 GERMANY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 134 GERMANY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 135 GERMANY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 136 FRANCE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 137 FRANCE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 138 FRANCE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 139 FRANCE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 140 FRANCE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 141 FRANCE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 142 FRANCE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 143 FRANCE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 144 FRANCE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 145 FRANCE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 146 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 147 FRANCE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 148 FRANCE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 149 FRANCE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 150 FRANCE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 151 FRANCE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 152 FRANCE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 153 FRANCE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 154 FRANCE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 155 FRANCE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 156 FRANCE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 157 FRANCE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 158 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 159 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 160 FRANCE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161 FRANCE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 162 FRANCE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163 FRANCE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164 FRANCE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165 FRANCE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 166 FRANCE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 167 FRANCE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 168 FRANCE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 169 FRANCE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 170 FRANCE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 171 FRANCE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 172 FRANCE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173 FRANCE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 174 U.K. OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 175 U.K. DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 176 U.K. SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 177 U.K. OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 178 U.K. VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 179 U.K. REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 180 U.K. GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 181 U.K. DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 182 U.K. OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 183 U.K. OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 184 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 185 U.K. ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 186 U.K. ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 187 U.K. PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 188 U.K. BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 189 U.K. ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 190 U.K. MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 191 U.K. ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 192 U.K. OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 193 U.K. VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 194 U.K. CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 195 U.K. OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 196 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 197 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 198 U.K. DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 199 U.K. TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200 U.K. LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201 U.K. INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 202 U.K. ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203 U.K. OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 204 U.K. REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 205 U.K. VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 206 U.K. INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 207 U.K. ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 208 U.K. VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 209 U.K. OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 210 U.K. OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 211 U.K. RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 212 ITALY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 213 ITALY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 214 ITALY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 215 ITALY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 216 ITALY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 217 ITALY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 218 ITALY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 219 ITALY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 220 ITALY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 221 ITALY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 222 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 223 ITALY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 224 ITALY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 225 ITALY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 226 ITALY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 227 ITALY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 228 ITALY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 229 ITALY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 230 ITALY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 231 ITALY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 232 ITALY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 233 ITALY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 234 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 235 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 236 ITALY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237 ITALY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 238 ITALY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239 ITALY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 240 ITALY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 241 ITALY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 242 ITALY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 243 ITALY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 244 ITALY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 245 ITALY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 246 ITALY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 247 ITALY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 248 ITALY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 249 ITALY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250 SPAIN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 251 SPAIN DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 252 SPAIN SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 253 SPAIN OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 254 SPAIN VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 255 SPAIN REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 256 SPAIN GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 257 SPAIN DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 258 SPAIN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 259 SPAIN OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 260 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 261 SPAIN ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 262 SPAIN ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 263 SPAIN PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 264 SPAIN BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 265 SPAIN ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 266 SPAIN MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 267 SPAIN ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 268 SPAIN OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 269 SPAIN VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 270 SPAIN CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 271 SPAIN OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 272 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 273 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 274 SPAIN DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 275 SPAIN TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276 SPAIN LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 277 SPAIN INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 278 SPAIN ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 279 SPAIN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 280 SPAIN REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 281 SPAIN VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 282 SPAIN INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 283 SPAIN ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 284 SPAIN VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 285 SPAIN OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 286 SPAIN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 287 SPAIN RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288 SWITZERLAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 289 SWITZERLAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 290 SWITZERLAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 291 SWITZERLAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 292 SWITZERLAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 293 SWITZERLAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 294 SWITZERLAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 295 SWITZERLAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 296 SWITZERLAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 297 SWITZERLAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 298 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 299 SWITZERLAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 300 SWITZERLAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 301 SWITZERLAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 302 SWITZERLAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 303 SWITZERLAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 304 SWITZERLAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 305 SWITZERLAND ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 306 SWITZERLAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 307 SWITZERLAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 308 SWITZERLAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 309 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 310 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 311 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 312 SWITZERLAND DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 313 SWITZERLAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 314 SWITZERLAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 315 SWITZERLAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 316 SWITZERLAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 317 SWITZERLAND OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 318 SWITZERLAND REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 319 SWITZERLAND VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 320 SWITZERLAND INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 321 SWITZERLAND ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 322 SWITZERLAND VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 323 SWITZERLAND OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 324 SWITZERLAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 325 SWITZERLAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 326 RUSSIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 327 RUSSIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 328 RUSSIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 329 RUSSIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 330 RUSSIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 331 RUSSIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 332 RUSSIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 333 RUSSIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 334 RUSSIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 335 RUSSIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 336 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 337 RUSSIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 338 RUSSIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 339 RUSSIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 340 RUSSIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 341 RUSSIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 342 RUSSIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 343 RUSSIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 344 RUSSIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 345 RUSSIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 346 RUSSIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 347 RUSSIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 348 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 349 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 350 RUSSIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 351 RUSSIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 352 RUSSIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 353 RUSSIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 354 RUSSIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 355 RUSSIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 356 RUSSIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 357 RUSSIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 358 RUSSIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 359 RUSSIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 360 RUSSIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 361 RUSSIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 362 RUSSIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 363 RUSSIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 364 BELGIUM OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 365 BELGIUM DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 366 BELGIUM SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 367 BELGIUM OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 368 BELGIUM VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 369 BELGIUM REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 370 BELGIUM GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 371 BELGIUM DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 372 BELGIUM OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 373 BELGIUM OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 374 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 375 BELGIUM ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 376 BELGIUM ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 377 BELGIUM PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 378 BELGIUM BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 379 BELGIUM ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 380 BELGIUM MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 381 BELGIUM ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 382 BELGIUM OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 383 BELGIUM VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 384 BELGIUM CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 385 BELGIUM OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 386 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 387 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 388 BELGIUM DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 389 BELGIUM TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 390 BELGIUM LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 391 BELGIUM INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 392 BELGIUM ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 393 BELGIUM OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 394 BELGIUM REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 395 BELGIUM VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 396 BELGIUM INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 397 BELGIUM ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 398 BELGIUM VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 399 BELGIUM OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 400 BELGIUM OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 401 BELGIUM RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 402 NETHERLANDS OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 403 NETHERLANDS DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 404 NETHERLANDS SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 405 NETHERLANDS OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 406 NETHERLANDS VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 407 NETHERLANDS REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 408 NETHERLANDS GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 409 NETHERLANDS DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 410 NETHERLANDS OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 411 NETHERLANDS OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 412 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 413 NETHERLANDS ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 414 NETHERLANDS ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 415 NETHERLANDS PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 416 NETHERLANDS BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 417 NETHERLANDS ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 418 NETHERLANDS MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 419 NETHERLANDS ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 420 NETHERLANDS OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 421 NETHERLANDS VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 422 NETHERLANDS CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 423 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 424 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 425 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 426 NETHERLANDS DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 427 NETHERLANDS TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 428 NETHERLANDS LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 429 NETHERLANDS INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 430 NETHERLANDS ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 431 NETHERLANDS OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 432 NETHERLANDS REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 433 NETHERLANDS VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 434 NETHERLANDS INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 435 NETHERLANDS ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 436 NETHERLANDS VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 437 NETHERLANDS OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 438 NETHERLANDS OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 439 NETHERLANDS RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 440 TURKEY OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 441 TURKEY DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 442 TURKEY SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 443 TURKEY OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 444 TURKEY VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 445 TURKEY REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 446 TURKEY GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 447 TURKEY DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 448 TURKEY OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 449 TURKEY OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 450 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 451 TURKEY ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 452 TURKEY ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 453 TURKEY PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 454 TURKEY BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 455 TURKEY ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 456 TURKEY MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 457 TURKEY ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 458 TURKEY OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 459 TURKEY VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 460 TURKEY CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
TABLE 461 TURKEY OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)
TABLE 462 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)
TABLE 463 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)
TABLE 464 TURKEY DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 465 TURKEY TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 466 TURKEY LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 467 TURKEY INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 468 TURKEY ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 469 TURKEY OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 470 TURKEY REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 471 TURKEY VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 472 TURKEY INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 473 TURKEY ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 474 TURKEY VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)
TABLE 475 TURKEY OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)
TABLE 476 TURKEY OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 477 TURKEY RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 478 REST OF EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)
図表一覧
FIGURE 1 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION
FIGURE 2 EUROPE OPHTHALMOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE OPHTHALMOLOGY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE OPHTHALMOLOGY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE OPHTHALMOLOGY MARKET: SEGMENTATION
FIGURE 11 THREE SEGMENTS COMPRISE THE EUROPE OPHTHALMOLOGY MARKET, BY PRODUCTS
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE EUROPE OPHTHALMOLOGY MARKET FROM 2025 TO 2032
FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE OPHTHALMOLOGY MARKET IN 2025 AND 2032
FIGURE 16 DROC ANALYSIS
FIGURE 17 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024
FIGURE 18 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)
FIGURE 19 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)
FIGURE 20 EUROPE OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE
FIGURE 21 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2024
FIGURE 22 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)
FIGURE 23 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)
FIGURE 24 EUROPE OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE
FIGURE 25 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024
FIGURE 26 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)
FIGURE 27 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)
FIGURE 28 EUROPE OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE
FIGURE 29 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2024
FIGURE 30 EUROPE OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)
FIGURE 31 EUROPE OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)
FIGURE 32 EUROPE OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024
FIGURE 34 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
FIGURE 35 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)
FIGURE 36 EUROPE OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 37 EUROPE OPHTHALMOLOGY MARKET SNAPSHOT
FIGURE 38 EUROPE OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
